PEI chemotherapy ups survival in sensitive relapsed SCLC, but at a cost

CHICAGO – Cisplatin, etoposide, and irinotecan provide a significant survival advantage over topotecan as second-line chemotherapy in sensitive relapsed small cell lung cancer, but the toxicity of...